Literature DB >> 30064295

"Phobie à deux" and other reasons why clinicians do not apply exposure with response prevention in patients with obsessive-compulsive disorder.

Steffen Moritz1, Anne Külz2, Ulrich Voderholzer3,4, Thomas Hillebrand5, Dean McKay6, Lena Jelinek1.   

Abstract

Meta-analyses suggest that exposure with response prevention (ERP) is the most efficacious treatment for obsessive-compulsive disorder (OCD) and treatment guidelines for the disorder accordingly recommend ERP. Despite this, many therapists, including those with a cognitive-behavioral therapeutic background, do not perform ERP in patients with OCD. The present study aimed to elucidate the reasons why. German therapists (N = 216) completed an anonymous online survey, the newly developed Reasons for Not Performing Exposure in OCD Scale (REPEX), that inquired whether, to what extent, and how they perform ERP in the treatment of OCD. We also asked their reasons for not applying ERP in the past. Most therapists considered ERP an efficient treatment for OCD. Marked differences emerged between physicians and psychologists, however. The former used exposure less often and for a shorter period, preferred in sensu to in vivo exposure, and conducted exposure less often in the personal environment of the patient than did psychologists. Both groups were familiar with clinical guidelines to a similar extent. A factor analysis of the REPEX scale revealed five factors. Patient lack of motivation, preference for exposure to be self-help as well as alleged organizational difficulties were endorsed most often. The latter was correlated with the age of the therapist and was far more often affirmed by physicians. Fear of side effects was named by a subgroup of clinicians; in the context of patient ambivalence, this may foster "phobie à deux". Unlike prior research, lack of expertise was rarely identified as a reason not to use ERP. Recommendations for improving adherence to guidelines are discussed.

Entities:  

Keywords:  Obsessive–compulsive disorder; adherence; exposure; guidelines

Mesh:

Year:  2018        PMID: 30064295     DOI: 10.1080/16506073.2018.1494750

Source DB:  PubMed          Journal:  Cogn Behav Ther        ISSN: 1650-6073


  4 in total

1.  Metacognitive Training for Obsessive-Compulsive Disorder: a study protocol for a randomized controlled trial.

Authors:  Franziska Miegel; Cüneyt Demiralay; Steffen Moritz; Janina Wirtz; Birgit Hottenrott; Lena Jelinek
Journal:  BMC Psychiatry       Date:  2020-07-06       Impact factor: 3.630

2.  Internet-based cognitive behavioral therapy in children and adolescents with obsessive compulsive disorder: a feasibility study.

Authors:  Karsten Hollmann; Katharina Allgaier; Carolin S Hohnecker; Heinrich Lautenbacher; Verena Bizu; Matthias Nickola; Gunilla Wewetzer; Christoph Wewetzer; Tord Ivarsson; Norbert Skokauskas; Lidewij H Wolters; Gudmundur Skarphedinsson; Bernhard Weidle; Else de Haan; Nor Christan Torp; Scott N Compton; Rosa Calvo; Sara Lera-Miguel; Anna Haigis; Tobias J Renner; Annette Conzelmann
Journal:  J Neural Transm (Vienna)       Date:  2021-08-25       Impact factor: 3.575

3.  Clinician-reported barriers to using exposure with response prevention in the treatment of paediatric obsessive-compulsive disorder.

Authors:  Julia Keleher; Amita Jassi; Georgina Krebs
Journal:  J Obsessive Compuls Relat Disord       Date:  2020-01       Impact factor: 1.677

4.  Determining prognostic variables of treatment outcome in obsessive-compulsive disorder: effectiveness and its predictors in routine clinical care.

Authors:  Philipp Herzog; Bernhard Osen; Christian Stierle; Thomas Middendorf; Ulrich Voderholzer; Stefan Koch; Matthias Feldmann; Winfried Rief; Eva-Lotta Brakemeier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-07-03       Impact factor: 5.270

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.